Analysts who monitor BioInvent
| Erik Hultgård | erik.hultgard@abgsc.se | ABG Sundal Collier, Stockholm |
| Camilla Oxhamre | camoxh@carnegie.se | Carnegie Investment Bank, Stockholm |
| Hans Jeppsson | haje@danskebank.com | Danske Bank |
| John Savin | jsavin@edisoninvestmentresearch.co.uk | Edison Investment Research |
| Olav Zilian | ozilian@helvea.com | Helvea, Geneva |
| Mark Pospisilik | mark.pospisilik@kempen.nl | Kempen & Co, Amsterdam |
| Olle Sjölin | olle.sjolin@nordea.com | Nordea Markets, Stockholm |
| Peter Östling, Klas Palin |
peter.ostling@redeye.se klas.palin@redeye.se |
Redeye, Stockholm |
| Johan Biehl | johan.biehl@remium.com | Remium, Stockholm |
| Yilmaz Mahshid | yilmaz.mahshid@ohman.se | Öhman Fondkommission, Stockholm |
BioInvent International • SE-223 70 Lund, Sweden • Visiting: Sölvegatan 41, Lund, Sweden • Tel: +46 (0)46-286 85 50 • E-mail: info@bioinvent.com